Studies have tested the therapeutic value of small inhibitory RNAs by introducing them to an animal model of disease. A new study takes the opposite tack: a specific endogenous inhibitory RNA is ablated in the mouse, resulting in a large decrease in serum cholesterol.
No takes yet. Share an insight, caveat, or question.
Michael Czech (2006) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: